Pure Global

Insulin syringe, fixed-needle

Access comprehensive regulatory information for Insulin syringe, fixed-needle in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Interpath Services Pty Ltd, manufactured by Jiangsu Caina Medical Co Ltd in China. The device registration started on April 26, 2023.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class IIa
Class IIa
Insulin syringe, fixed-needle
Australia TGA ARTG Registered Device
Good Name: Interpath Services Pty Ltd - Insulin syringe, fixed-needle
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

Syringes for single use with integrated hypodermic cannula for subcutaneous injection of insulin

Device Classification
Risk Class
Class IIa
Product Type
Single Device Product
ARTG Category
General
Registration Information
Start Date
April 26, 2023
Effective Date
April 26, 2023
Manufacturer
Country
China
Address
No 23 Huanxi Road Zhutang Town Jiangyin City, Jiangsu, 214415